Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00109148 | An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006) | PHASE2 | COMPLETED | 500 | — | — | Jul 1, 2004 | Feb 1, 2005 | Sep 9, 2015 | - | — |
| Name | Type | Description |
|---|---|---|
| MK0364 | DRUG | - |
Inclusion Criteria: * Patients who are obese (considerably overweight) based on body mass index. Exclusion Criteria: * Patients with serious or unstable current or past medical conditions